Develops drugs for neurological, oncologic, and inflammatory diseases.
Jun 2026Revenue $35.0K/yrExpenses $5.14M/yr
No trendCash runway ≈ 1 months from Mar 2026
Figures by year
When will Impact Biomedical be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $35.0K and expenses $5.14M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $32.0K | $4.31M | −$4.28M |
| Dec 2022 | $50.0K | $3.45M | −$3.40M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.